Onco360 Has Been Selected as a National Specialty Pharmacy for Augtyro(TM) (repotrectinib)
Onco360 Has Been Selected as a National Specialty Pharmacy for Augtyro(TM) (repotrectinib) GlobeNewswire July 07, 2025 LOUISVILLE, Ky., July 07, 2025 (GLOBE NEWSWIRE) — Onco360(R), the nation's leading independent specialty pharmacy, has added Augtyro(TM) (repotrectinib) manufactured by Bristol Myers Squibb to its comprehensive list of limited distribution therapies. Augtyro was initially approved on November 15, […]